ZIOPHARM Oncology Inc (ZIOP)

5.48
NASDAQ : Health Care
Prev Close 5.48
Day Low/High 0.00 / 0.00
52 Wk Low/High 4.45 / 14.93
Avg Volume 2.08M
Exchange NASDAQ
Shares Outstanding 131.73M
Market Cap 723.21M
EPS -1.00
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

ZIOP April 2017 Options Begin Trading

ZIOP April 2017 Options Begin Trading

Investors in ZIOPHARM Oncology Inc saw new options begin trading today, for the April 2017 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 242 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Ziopharm Oncology (ZIOP) Stock Advances After Q2 Results, Upgrade

Ziopharm Oncology (ZIOP) Stock Advances After Q2 Results, Upgrade

Ziopharm Oncology (ZIOP) reported stronger-than-expected results for the 2016 second quarter following Tuesday's closing bell.

ZIOPHARM Reports Second-Quarter 2016 Financial Results And Provides Update On Recent Activities

ZIOPHARM Reports Second-Quarter 2016 Financial Results And Provides Update On Recent Activities

Company to Host Conference Call at 4:30 PM ET Today

Today's Weak On High Volume Stock: ZIOPHARM Oncology (ZIOP)

Today's Weak On High Volume Stock: ZIOPHARM Oncology (ZIOP)

Trade-Ideas LLC identified ZIOPHARM Oncology (ZIOP) as a weak on high relative volume candidate

Today's Dead Cat Bounce Stock Is ZIOPHARM Oncology (ZIOP)

Today's Dead Cat Bounce Stock Is ZIOPHARM Oncology (ZIOP)

Trade-Ideas LLC identified ZIOPHARM Oncology (ZIOP) as a "dead cat bounce" (down big yesterday but up big today) candidate

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Into Possible Securities Fraud Violations By Certain Officers And Directors Of ZIOPHARM Oncology, Inc.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Into Possible Securities Fraud Violations By Certain Officers And Directors Of ZIOPHARM Oncology, Inc.

Levi & Korsinsky announces it has commenced an investigation of ZIOPHARM Oncology, Inc.

Federman & Sherwood Investigates ZIOPHARM Oncology, Inc. For Possible Violations Of Federal Securities Laws

Federman & Sherwood Investigates ZIOPHARM Oncology, Inc. For Possible Violations Of Federal Securities Laws

The law firm of Federman & Sherwood has initiated an investigation into ZIOPHARM Oncology, Inc.

Why Ziopharm (ZIOP) Stock Is Tanking Today

Why Ziopharm (ZIOP) Stock Is Tanking Today

Ziopharm (ZIOP) stock is plunging in pre-market trading Friday after a brain cancer patient died soon after being injected with a gene therapy from the biopharmaceutical company.

Trade-Ideas: ZIOPHARM Oncology (ZIOP) Is Today's Pre-Market Mover With Heavy Volume Stock

Trade-Ideas: ZIOPHARM Oncology (ZIOP) Is Today's Pre-Market Mover With Heavy Volume Stock

Trade-Ideas LLC identified ZIOPHARM Oncology (ZIOP) as a pre-market mover with heavy volume candidate

Brain Tumor Patient Dies After Ziopharm Gene Therapy Injection

Brain Tumor Patient Dies After Ziopharm Gene Therapy Injection

The circumstances surrounding the Ziopharm patient deaths come amid heightened scrutiny of experimental anti-cancer therapies.

Juno Patient Deaths Crash Cancer-Killing CAR-T Party

Juno Patient Deaths Crash Cancer-Killing CAR-T Party

The lead CAR-T program of Juno Therapeutics has been placed on a clinical hold by U.S. regulators following the deaths of two patients in a pivotal clinical trial.

Trade-Ideas: ZIOPHARM Oncology (ZIOP) Is Today's

Trade-Ideas: ZIOPHARM Oncology (ZIOP) Is Today's "Perilous Reversal" Stock

Trade-Ideas LLC identified ZIOPHARM Oncology (ZIOP) as a "perilous reversal" (up big yesterday but down big today) candidate

Ziopharm Co-Dependency Spirals Down in Amended Intrexon Deal

Ziopharm Co-Dependency Spirals Down in Amended Intrexon Deal

The amended agreement with Intrexon bolsters the bear argument against Ziopharm that its entire cancer drug pipeline is mediocre and overvalued.

Interesting ZIOP Put And Call Options For August 19th

Interesting ZIOP Put And Call Options For August 19th

Investors in ZIOPHARM Oncology Inc saw new options begin trading this week, for the August 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ZIOP options chain for the new August 19th contracts and identified one put and one call contract of particular interest.

Commit To Buy ZIOPHARM Oncology At $3, Earn 25% Using Options

Commit To Buy ZIOPHARM Oncology At $3, Earn 25% Using Options

Investors considering a purchase of ZIOPHARM Oncology Inc shares, but cautious about paying the going market price of $6.05/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2018 put at the $3 strike, which has a bid at the time of this writing of 75 cents.